Skip to main content
    S

    Surrozen Inc (SRZN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $29.98
    -2.34 (-7.24%)

    Market Cap: $602.54M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Surrozen Inc (SRZN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Surrozen (SRZN) has a market cap of $602.54M and an enterprise value of $502.19M. It kept -3706.41% of revenue as net income over the last 12 months. Revenue grew 192.12% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 16.66% below the market cap, as cash exceeds debt.

    Market Cap$602.54M
    Enterprise Value$502.19M
    Latest price (Nov 17, 2026)$29.98

    Key Dates

    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.95% in the quarter ended Sep 30, 2026 and grew 90.98% a year over 2 years.

    Shares Outstanding11.77M
    Shares Change (YoY)+37.37%
    Shares Change (QoQ)+0.95%
    Share Count Growth (2Y CAGR)+90.98%

    Valuation Ratios

    The price to sales ratio is 33.5x. Its year-end P/S ranged from 1.4x to 40.4x from 2022 to 2025.

    P/S Ratio33.5x
    Forward P/S59.1x

    Price Statistics

    The stock is up 130.97% over 52 weeks and trades 14.08% above its 50-day average.

    Beta (1Y)1.51
    52-Week Change+130.97%
    1-Month Change+25.75%
    3-Month Change+24.86%
    6-Month Change+17.25%
    5-Year Change-72.33%
    Total Return (1Y)+130.97%
    Total Return (3Y CAGR)+63.16%
    Total Return (5Y CAGR)-27.25%
    Return vs SPY (1Y)+119.95%
    Max Drawdown (1Y)-52.65%
    Max Drawdown (3Y)-61.81%
    Sharpe Ratio (1Y)0.77
    Correlation with SPY (1Y)0.19
    50-Day Average$26.28
    200-Day Average$25.73
    52-Week Range$12.79 to $37.83
    RSI (14 Days)52.6
    Average Volume (20 Days)273.03K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 7.56x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio7.56x
    Quick Ratio7.56x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on Assets (ROA)-357.88%
    ROIC (5Y Average)59.56%
    Asset Turnover0.10x
    Receivables Turnover4.21x

    Scores

    SRZN has an Altman Z-Score of -14.04, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-14.04
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $10.53M over the last 12 months.

    Revenue$10.53M
    Revenue Growth (YoY)+192.12%
    Gross Profit$10.53M
    Operating Income-$51.11M
    Pretax Income-$200.14M
    Net Income-$390.21M
    Reported EPS (TTM)-$19.41

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$100.35M
    Total Debt$0
    Net Cash$100.35M
    Net Cash Per Share$8.52
    Working Capital$89.28M
    Shareholder Equity-$335.62M
    Total Assets$109.03M
    Total Liabilities$444.66M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $225.00K of capital spending, operating cash flow left -$30.77M of free cash flow.

    Operating Cash Flow-$30.55M
    Capital Expenditures$225.00K
    Free Cash Flow-$30.77M
    FCF Per Share-$1.76
    Depreciation and Amortization$212.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -485.44%.

    Gross Margin100.00%
    Operating Margin-485.44%
    Pretax Margin-1901.04%
    Net Margin-3706.41%
    FCF Margin-292.32%

    Dividends and Yields

    SRZN does not pay a dividend. Its free cash flow yield is -8.72%.

    FCF Yield-8.72%
    Buyback Yield-11.27%
    Shareholder Yield-11.27%

    Stock Splits

    The last split was a 1-for-15 reverse split on Dec 14, 2023.

    Last Split DateDec 14, 2023
    Split TypeReverse split
    Split Ratio1:15

    Peer Position

    Against 4 similar companies, SRZN has the highest P/S.

    P/S Ratio33.5x vs 6.2x median
    Revenue Growth (Trailing 4 Quarters, YoY)+192.12% vs -84.64% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -52.03% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-52.03%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SRZN

    What is SRZN's market cap?

    Surrozen has a market cap of $602.54M. Its enterprise value, which adds debt and subtracts cash, is $502.19M.

    How many shares of SRZN are outstanding?

    Surrozen has 11.77M shares outstanding. The count is up 37.37% from a year earlier.

    Does SRZN pay a dividend?

    No. Surrozen does not pay a dividend.

    How much debt does SRZN have?

    Surrozen has $0 of total debt and $100.35M of cash and equivalents, a net cash position of $100.35M.